Table 3.
Patients and ICU stay characteristics in the matched analysis
| COVID patients | Non-COVID patients | p-value | |
|---|---|---|---|
| (n = 404) | (n = 666) | ||
| Age | |||
| Median (range) (IQR) | 82 (80–95) (81–84) | 82 (80–94) (81–84) | 0.33 |
| Gender | |||
| Male | 286 (70.8%) | 484 (72.7%) | 0.55 |
| Female | 118 (29.2%) | 182 (27.3%) | |
| Frailty | |||
| Fit (CFS 1–3) | 209 (51.7%) | 360 (54.1%) | 0.51 |
| Vulnerable (CFS 4) | 87 (21.5%) | 149 (22.4%) | |
| Frail (CFS 5–8) | 108 (26.7%) | 157 (23.6%) | |
| Sofa | |||
| Med (range) (IQR) | 5 (0–15) (3–8) | 5 (0–15) (3–7) | 0.66 |
| Katz | |||
| Med (range) (IQR) | 6 (0–6) (5–6) | 6 (0–6) (5–6) | 0.93 |
| Mechanical ventilation | |||
| Yes | 225 (56%) | 293 (44%) | < 0.0002 |
| NIV | |||
| Yes | 128 (32.1%) | 335 (50.3%) | < 0.0001 |
| Vasoactive drugs | |||
| Yes | 225 (56.1%) | 323 (48.5%) | 0.019 |
| Renal replacement therapy | |||
| Yes | 36 (9%) | 50 (7.5%) | 0.46 |
| ICU LOS in alive patients | |||
| Med (range) (IQR) | 7 (0.08–54) (3.4–14.0) | 4.98 (0.08–100) (2.42–9.7) | < 0.0004 |
| ICU LOS in dead patients | |||
| Med (range) (IQR) | 7.96 (0.08–53) (3.38–14) | 5.92 (0.08–60) (2.08–9.27) | < 0.0009 |